Global Biotechnology Leader Microbiologics Receives 2023 Minnesota Governor’s International Trade Award
Saint Cloud, Minnesota, USA – Minnesota-based biotechnology manufacturer and contract research organization, Microbiologics, has been named a recipient of the 2023 Minnesota Governor’s International Trade Awards. The award recognizes Minnesota companies that have shown exceptional progress and success in exports to foreign markets. Microbiologics is a global leader in infectious disease biomaterials and anti-infective research, focused on protecting the health and safety of people throughout the world. The Governor’s International Trade Award recipients are selected in collaboration with the Minnesota Trade Office and Department of Employment and Economic Development; seven companies were recognized this year.
Headquartered in Saint Cloud, Minnesota and founded in 1971, Microbiologics has been supporting microbiology, virology and molecular diagnostic laboratories for more than 50 years. They specialize in producing test-ready infectious disease reference standards and quality controls. They also provide custom biological materials and testing services to support diagnostic technology and anti-infective drug and vaccine developers, from product conception through commercialization and post-market surveillance.
Microbiologics’ catalog of 2,600 infectious disease quality control products is sold through a network of more than 160 distribution partners servicing 142 countries across the globe. The company is known for leading the industry in their adoption of international quality standards, most recently receiving the European Union (EU) In Vitro Diagnostic Regulation (IVDR) certification of their KWIK-STIK™ QC microorganisms and Helix Elite™ molecular standards. They have also partnered with leading international pharmaceutical and biotechnology companies to aid in the research and development of anti-infective drugs and vaccines, including those for treating Mycobacterium tuberculosis (MTB), Influenza and SARS-CoV-2.
Microbiologics was at the forefront of responding to the global COVID-19 pandemic. With a highly specialized team and ample Biosafety Level 3 (BSL-3) laboratory space, Microbiologics provided inactivated SARS-CoV-2 quality controls, custom viral stocks and assay services to their partners on the frontlines in healthcare, and those developing diagnostic technologies and vaccines within the USA and internationally.
“At Microbiologics, we are proud to support our fellow scientists around the world. It’s an incredible honor to be recognized for our international trade accomplishments. We remain committed to sharing our expertise in microbiology and virology to create a safer, healthier world,” commented Microbiologics Chief Executive Officer, Kristen Knox.
About Microbiologics: Microbiologics is the foremost biological products and services provider, focused on protecting the health and safety of people around the world. For over 50 years, they have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, the company has additional facilities in Michigan, Kentucky and California. Microbiologics has advanced industry standards for biological controls by adopting the most rigorous testing and quality standards. The company has an extensive distribution network spanning over 150 countries. For more information, visit Microbiologics, Inc.